Updated
Updated · The Washington Post · Sep 23
Senate Democrats Demand Release of 24-Plus Trump Drug-Price Contracts
Updated
Updated · The Washington Post · Sep 23

Senate Democrats Demand Release of 24-Plus Trump Drug-Price Contracts

3 articles · Updated · The Washington Post · Sep 23

Summary

  • Senate Democrats renewed demands that the Trump administration disclose contracts negotiated with more than two dozen pharmaceutical companies under its drug-price initiative.
  • Lawmakers said they cannot assess whether the program is actually lowering prices until the agreements are made public.
  • The push follows a Washington Post report on the contracts and sharpens scrutiny of an administration effort billed as a major prescription-drug cost cut.

Insights

What hidden concessions might pharmaceutical giants be receiving behind closed doors in exchange for these highly publicized drug price cuts?